Robin M Pokrzywinski

No ORCID on file · 6 papers in corpus · active 2019-2020

Study types

  • article 5
  • other 1

Condition tags

  • mesh:D004715 6
  • endometriosis 6
  • mesh:D017699 3
  • mesh:D004412 2
  • dysmenorrhea 2
  • mesh:D004414 1
  • dyspareunia 1
article 2020
Clinically Meaningful Reduction in Dyspareunia Is Associated with Significant Improvements in Health-Related Quality of Life Among Women with Moderate to Severe Pain Associated with Endometriosis: A Pooled Analysis of Two Phase III Trials of Elagolix
The journal of sexual medicine ·doi:10.1016/j.jsxm.2020.08.002

BACKGROUND: Dyspareunia experienced by women diagnosed with endometriosis is associated with a decreased health-related quality of life (HRQoL). AIM: We evaluated the relationship of clinically meaningful improvements in dyspareunia with HR…

other 2020
Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix
Obstetrics and gynecology ·doi:10.1097/AOG.0000000000003917

OBJECTIVE: To evaluate the effects of elagolix on clinically meaningful improvements in health-related quality of life (HRQOL) measured by the EHP-30 (Endometriosis Health Profile-30). METHODS: Data from two phase III trials of elagolix fo…

article 2020
Responsiveness and thresholds for clinically meaningful changes in worst pain numerical rating scale for dysmenorrhea and nonmenstrual pelvic pain in women with moderate to severe endometriosis
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.07.013
article 2019
Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: analysis of 2 phase III clinical trials
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2019.11.1255
article 2019
Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trials
Fertility and sterility ·doi:10.1016/j.fertnstert.2019.04.031

ObjectiveTo estimate the impact of elagolix on work loss due to endometriosis-associated pain.DesignPost hoc analysis of data from the Elaris I and II clinical trials.SettingNot applicable.Patient(s)Employed women ages 18–49 years with mode…

article 2019
Psychometric assessment of the health-related productivity questionnaire (HRPQ) among women with endometriosis
Expert review of pharmacoeconomics & outcomes research ·doi:10.1080/14737167.2019.1662301

Objective: Endometriosis impacts health-related quality of life. The objective was to assess the validity and responsiveness of the Health-Related Productivity Questionnaire, version 2 (HRPQ).Methods: Outcome measures (Endometriosis Health …